Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
Purity 99% by HPLC analysis Form Lyophilised powder, single-use vials Storage (long-term) 20 C, desiccated, from light Storage (short-term) 28 C, up to 4 weeks Receptor profile GLP-1R, GIPR, and GCGR agonism Classification Research Use Only (RUO) Testing Independent third-party batch verification Documentation Certificate of Analysis (COA) per batch Scientific Overview Compound Background Retatrutide Europe is a 39-amino acid fatty acid-acylated peptide developed by Eli Lilly and Company as a next-generation metabolic research candidate
/assets/images/provider/photos/2764437.jpeg)
Canadas story is a little different
10.2741/2787 64 HawleyS
Smit FX, van der Velden WJC, Kizilkaya HS, et al
Review our documentation policy This item is intended for qualified laboratory purchasers only
US$ 21.78
US$ 20.43
US$ 25.95
:max_bytes(150000):strip_icc()/VWH-GettyImages-1485130572-8074b2ff59114d1496862c9daf11d676.jpg)
US$ 23.61
